Identity of inhibitory presynaptic 5-hydroxytryptamine (5-HT) autoreceptors in the rat brain cortex with 5-HT1B binding sites
暂无分享,去创建一个
E. Schlicker | D. Hoyer | E. Schlicker | G. Engel | D. Hoyer | G. Engel | M. Göthert | K. Hillenbrand | M. Göthert | K. Hillenbrand
[1] J. Traber,et al. 3H-TVX Q 7821: identification of 5-HT1 binding sites as target for a novel putative anxiolytic , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.
[2] J. Gaddum,et al. TWO KINDS OF TRYPTAMINE RECEPTOR , 1997, British journal of pharmacology and chemotherapy.
[3] K. Starke. Presynaptic receptors. , 1981, Annual review of pharmacology and toxicology.
[4] F. Artaud,et al. Biochemical evidence for the 5-HT agonist properties of PAT (8-hydroxy-2-(di-n-propylamino)tetralin) in the rat brain. , 1984, European journal of pharmacology.
[5] M. Göthert,et al. Extracellular 5-hydroxytryptamine inhibits 5-hydroxytryptamine release from rat brain cortex slices , 1979, Naunyn-Schmiedeberg's Archives of Pharmacology.
[6] J. Palacios,et al. β-Adrenoceptor blocking agents recognize a subpopulation of serotonin receptors in brain , 1985, Brain Research.
[7] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[8] E. Schlicker,et al. Autoreceptor-mediated inhibition of 3H-5-hydroxytryptamine release from rat brain cortex slices by analogues of 5-hydroxytryptamine. , 1983, Life sciences.
[9] E. Schlicker,et al. Cyanopindolol is a highly potent and selective antagonist at the presynaptic serotonin autoreceptor in the rat brain cortex , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.
[10] Regulation of release processes in central serotoninergic neurons. , 1981, Journal de physiologie.
[11] R. Furchgott. The Classification of Adrenoceptors (Adrenergic Receptors). An Evaluation from the Standpoint of Receptor Theory , 1972 .
[12] P. Waldmeier,et al. Further evidence for negative feedback control of serotonin release in the central nervous system , 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.
[13] W. Vaatstra,et al. Du 24565, a quipazine derivative, a potent selective serotonin uptake inhibitor. , 1981, European journal of pharmacology.
[14] J. Leysen,et al. [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.
[15] M. Göthert,et al. Characterization of the receptor subtype involved in alpha-adrenoceptor-mediated modulation of serotonin release from rat brain cortex slices , 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.
[16] J. Palacios,et al. Mesulergine, a selective serotonin-2 ligand in the rat cortex, does not label these receptors in porcine and human cortex: evidence for species differences in brain serotonin-2 receptors. , 1984, European journal of pharmacology.
[17] S. Snyder,et al. Two distinct central serotonin receptors with different physiological functions. , 1981, Science.
[18] M. Göthert,et al. Serotonin-receptor-mediated modulation of Ca2+-dependent 5-hydroxytryptamine release from neurones of the rat brain cortex , 1980, Naunyn-Schmiedeberg's Archives of Pharmacology.
[19] D. Middlemiss. Stereoselective blockade at [3H]5-HT binding sites and at the 5-HT autoreceptor by propranolol. , 1984, European journal of pharmacology.
[20] J. Palacios,et al. The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site. , 1984, European journal of pharmacology.
[21] E. Schlicker,et al. Effects of DU 24565 (6-nitroquipazine) on serotoninergic and noradrenergic neurones of the rat brain and comparison with the effects of quipazine , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.
[22] H A Feldman,et al. Mathematical theory of complex ligand-binding systems of equilibrium: some methods for parameter fitting. , 1972, Analytical biochemistry.
[23] J. Palacios,et al. Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors , 1985, Brain Research.
[24] H. Yamamura,et al. Discrimination of Multiple [3H]5‐Hydroxytryptamine Binding Sites by the Neuroleptic Spiperone in Rat Brain , 1981, Journal of neurochemistry.
[25] E. sanders-Bush,et al. Comparison of the pharmacological characteristics of 5 HT1 and 5 HT2 binding sites with those of serotonin autoreceptors which modulate serotonin release , 1982, Naunyn-Schmiedeberg's Archives of Pharmacology.
[26] M. Richards. Efflux of 3H-5-hydroxytryptamine from rat hypothalamic slices by continuous electrical stimulation: Frequency-dependent responses to serotonergic antagonists and 5-hydroxytryptamine , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.
[27] D. Middlemiss. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.
[28] J. Fozard. Functional correlates of 5-HT1 recognition sites , 1983 .
[29] D. Hoyer,et al. Characterization of the 5-HT1B recognition site in rat brain: binding studies with (-)[125I]iodocyanopindolol. , 1985, European journal of pharmacology.
[30] J. Glowinski,et al. Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT , 1983, Nature.
[31] R. Squires,et al. Effects of 5HT uptake inhibitors on the pressor response to 5HT in the pithed rat. The significance of the 5HT blocking property. , 1977, European journal of pharmacology.
[32] R. Lefkowitz,et al. A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.
[33] E. sanders-Bush,et al. The serotonin autoreceptor: Antagonism by quipazine , 1982, Neuropharmacology.
[34] R. Schnellmann,et al. 3H-serotonin binding sites: pharmacological and species differences. , 1983, Advances in biochemical psychopharmacology.
[35] M. Göthert. Modulation of serotonin release in the brain via presynaptic receptors , 1982 .
[36] L. Sistonen,et al. Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves , 1983, Naunyn-Schmiedeberg's Archives of Pharmacology.
[37] E. Schlicker,et al. Antagonistic properties of quipazine at presynaptic serotonin receptors and α-adrenoceptors in rat brain cortex slices , 1981, Naunyn-Schmiedeberg's Archives of Pharmacology.
[38] D. Middlemiss,et al. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. , 1983, European journal of pharmacology.
[39] S H Snyder,et al. Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.
[40] D. Hoyer,et al. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin. , 1985, European journal of pharmacology.
[41] C. Moret,et al. Citalopram antagonizes the stimulation by lysergic acid diethylamide of presynaptic inhibitory serotonin autoreceptors in the rat hypothalamus. , 1982, The Journal of pharmacology and experimental therapeutics.